Disease Modifying Status Targeted As Kolon's Novel OA Therapy Enters US Phase III

 
• By Jung Won Shin
Osteoarthritis
Kolon Looks For Disease-Modifying Claim As Novel OA Therapy Set For US Phase III • Source: Shutterstock

More from Clinical Trials

More from R&D